BWS Financial maintains Sell rating on Twist Bioscience
BWS Financial maintained a Sell rating on Twist Bioscience, with a $45.00/share price target, per Benzinga.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.